Efficacy of vedolizumab (VDZ) by disease localisation in Crohn's disease

被引：0
|
作者：
Allez, M. [1 ]
Braegger, F. [2 ]
Kempf, C. [2 ]
Michetti, P. [3 ,4 ]
机构：
[1] Univ Paris 07, Hop St Louis, AP HP, INSERM,UMRS 1160,Gastroenterol & Hepatol, Paris, France
[2] Takeda Pharmaceut Int AG, Zurich, Switzerland
[3] CHU Vaudois, Crohns & Colitis Ctr, Gastroenterol Source Beaulieu, Lausanne, Switzerland
[4] CHU Vaudois, Crohns & Colitis Ctr, Div Gastroenterol, Lausanne, Switzerland
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：S479 / S479
页数：1
相关论文
共 50 条
  • [21] VEDOLIZUMAB TREATMENT IN CROHN'S DISEASE OF THE POUCH
    Khan, Freeha
    Singh, Amandeep
    Hull, Tracy L.
    Shen, Bo
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S591 - S592
  • [22] Efficacy of vedolizumab in patients with Crohn's disease may differ depending on the disease location: The UCLH experience
    Kumagai, T.
    Vinayaga-Pavan, M.
    Parisi, I.
    Barragry, J.
    Sundramoorthi, R.
    Whitley, L.
    Parker, H.
    Kettle, R.
    McCabrey, N.
    Seward, E.
    McCartney, S.
    Bloom, S.
    Vega, R.
    Mehta, S.
    Rahman, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S420 - S421
  • [23] Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease
    Gonczi, Lorant
    Bessissow, Talat
    Lakatos, Peter
    [J]. GASTROENTEROLOGY, 2019, 157 (04) : 925 - 927
  • [24] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease Patients Stratified by Age
    Yajnik, Vijay
    Khan, Nabeel
    Dubinsky, Marla
    Axler, Jeffrey
    James, Alexandra
    Abhyankar, Brihad
    Lasch, Karen
    [J]. ADVANCES IN THERAPY, 2017, 34 (02) : 542 - 559
  • [25] Long term efficacy of ustekinumab in Crohn's disease patients after vedolizumab failure
    Melotti, L.
    Dussias, N. K.
    Belluzzi, A.
    Salice, M.
    Calabrese, C.
    Rizzello, F.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I408 - I408
  • [26] Long term efficacy of ustekinumab in Crohn's disease patients after vedolizumab failure
    Melotti, L.
    Dussias, N. K.
    Belluzzi, A.
    Salice, M.
    Calabrese, C.
    Rizzello, F.
    Gionchetti, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I408 - I408
  • [27] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
    Vijay Yajnik
    Nabeel Khan
    Marla Dubinsky
    Jeffrey Axler
    Alexandra James
    Brihad Abhyankar
    Karen Lasch
    [J]. Advances in Therapy, 2017, 34 : 542 - 559
  • [28] Cigarette smoking and Crohn's disease: Effect on disease localisation
    Hurlstone, DP
    Carter, MJ
    Sanders, DS
    Mitchell, S
    Harclerode, Z
    Lobo, AJ
    [J]. GUT, 2002, 50 : A71 - A71
  • [29] Nodular Vasculitis in a Patient With Crohn's Disease on Vedolizumab
    Pouldar, Delila
    Elsensohn, Ashley
    Ortenzio, Francesca
    Shiu, Jessica
    McLeod, Michael
    de Feraudy, Sebastien
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2018, 40 (03) : E36 - E37
  • [30] Vedolizumab for induction and maintenance of remission in Crohn's disease
    Hui, Samuel
    Sinopoulou, Vassiliki
    Gordon, Morris
    Aali, Ghazaleh
    Krishna, Anuj
    Ding, Nik Sheng
    Boyapati, Ray K.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (07):
12345